MindMaze Therapeutics Holding S.A. (0QKQ.L) LSE
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
MindMaze Therapeutics Holding S.A.
Address
Avenue de Secheron 15
Geneva, 1202
Switzerland
Phone
+41 21 532 08 60
Sector
Healthcare
Industry
Biotechnology
Employees
31
First IPO Date
January 18, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Zach W. Henderson | Chief Executive Officer | 542,580 | N/A |
| Zachery W. Henderson | Chief Executive Officer | 542,580 | 1973 |
| Paolo Galfetti | Chief Business Officer | 526,057 | 1965 |
| Alexandre Capet | Chief Operating & Strategy Officer | 0 | 1973 |
| Frédéric Condolo | Chief Technology Officer | 0 | 1973 |
| Jeremy Meinen | Chief Financial Officer | 0 | 1989 |
AD
Description
MindMaze Therapeutics Holding SA specializes in creating cutting-edge, AI-enhanced neurotherapeutics and pharmaceutical solutions aimed at treating various brain disorders. The firm concentrates its efforts on addressing both neurological and neuropsychiatric conditions by employing advanced research, thorough clinical development, and innovative technological approaches. Its main operational base is located in Geneva, Switzerland.
AD
